neoplasms. Malignant neoplasms
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: inclusion criteria: who had been received chemotherapy include Oxaliplatine or Cisplatine; have experienced at least minimum symptoms of neuropathic pain and nausea and vomiting and pain and fatigue; filled in patient's consent; aged above 16 years; Platelet above 50000; WBC more than 2500; positive olfactory test; negative sensitivity test and Exclusion criteria are: disorientation to time and place and person; known mental disorder; DVT; coagulation disorder; skin problem; bone fraction and extensive bruise
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Nausea and vomiting. Timepoint: 1hour before,24 hours and 2 days after intervention. Method of measurement: MASCC Anti Emetic Tool.;Fatigue. Timepoint: 1 hour before each intervention, 24 hour and 48 hour after each intervention. Method of measurement: Schwart's Fatigue Scale.;Pain. Timepoint: 1 hour before each intervention, 24 hour and 48 hour after each intervention. Method of measurement: Brief Pain Inventory.;Neuropathy. Timepoint: 1 hour before and 7 days after each intervention. Method of measurement: FACT-GOG questionnaire for neuropathy. | — |
Countries
Iran (Islamic Republic of)
Contacts
Yasuj University of Medical Sciences